Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    J Exp Med. 2006 Oct 2;203(10):2223-7. Epub 2006 Sep 25.

    Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade.

    Source

    Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. gordon_freeman@dfci.harvard.edu

    Abstract

    The programmed death (PD)-1-PD-1 ligand (PD-L) pathway, which is part of the B7-CD28 family, consists of the PD-1 receptor and its two ligands PD-L1 and PD-L2. Engagement of PD-1 by its ligands inhibits immune responses, and recent work has shown that PD-1 is highly expressed on exhausted T cells during chronic lymphocytic choriomeningitis virus (LCMV) infection in mice. Blockade of this pathway reinvigorates the exhausted T cells, allowing them to expand and produce effector cytokines, raising the issue of whether this pathway has been exploited by a variety of viruses during chronic infection. New studies now extend these observations to HIV infection and human disease.

    PMID:
    17000870
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2118103
    Free PMC Article

    Images from this publication.See all images (2)Free text

    Figure 1.
    Figure 2.

      Supplemental Content

      Icon for HighWire Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk